Onychomycosis Market Size
The size is a key indicator of its robust economic health and vital role in the dermatology industry. In 2025, the market was valued at approximately $3.51 billion, a testament to the immense global demand for treatments addressing this highly prevalent fungal infection. This valuation is a direct result of the increasing global prevalence of onychomycosis, which affects a significant portion of the population, particularly the elderly. The market size is also influenced by the continuous and repetitive use of both topical and oral treatments, as well as the growing adoption of new, often more expensive, laser therapies.
The market size is projected to expand significantly, with forecasts indicating a value of around $4.37 billion by 2030. This anticipated growth reflects the ongoing demographic and technological shifts in healthcare. The market's expansion is fueled by innovations in treatment, such as the development of more effective topical solutions and device-based therapies, which improve patient outcomes and increase demand. Furthermore, the growing trend of patient awareness and self-management is expanding the customer base and driving a need for over-the-counter and prescription treatments. While challenges such as the high recurrence rate of the infection and the long duration of treatment exist, the indispensable nature of onychomycosis care ensures a stable economic foundation and a steadily growing market size.